<SEC-DOCUMENT>0001437749-19-007119-index.html : 20190412
<SEC-HEADER>0001437749-19-007119.hdr.sgml : 20190412
<ACCEPTANCE-DATETIME>20190412180457
ACCESSION NUMBER:		0001437749-19-007119
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190411
FILED AS OF DATE:		20190412
DATE AS OF CHANGE:		20190412

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Tucker Sean
		CENTRAL INDEX KEY:			0001652204

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35285
		FILM NUMBER:		19747197

	MAIL ADDRESS:	
		STREET 1:		385 OYSTER POINT BLVD., SUITE 9A
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vaxart, Inc.
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		290 UTAH AVE., SUITE 200
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 550-3500

	MAIL ADDRESS:	
		STREET 1:		290 UTAH AVE., SUITE 200
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aviragen Therapeutics, Inc.
		DATE OF NAME CHANGE:	20160413

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biota Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20121113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20100719
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>rdgdoc.xml
<DESCRIPTION>4/11/19 OFFERING TUCKER
<TEXT>
Document 1 - file: rdgdoc.html

Document 1 - RAW XML: rdgdoc.xml

</DOCUMENT>
</SEC-DOCUMENT>